ESMO scientific and educational resources on this topic
Recent medwireNews and resources from conferences are for ESMO Members only.
Tumour Sites: Sarcomas
Sarcoma & GIST plus CUP
Latest ESMO videos
Featured medwireNews
Lenvatinib Plus Chemotherapy Promising For Relapsed, Refractory Osteosarcoma
Extended High-Risk GIST Follow-Up Confirms 3-Year Adjuvant Imatinib Benefit
Soft Tissue Sarcoma Patients Do Not Benefit From Histology-Tailored Neoadjuvant Chemotherapy
Paclitaxel Plus ART Best For AIDS-Related Kaposi Sarcoma In Limited-Resource Settings
Clinically Relevant Genomic Alterations Identified In Two-Fifths of Soft-Tissue Sarcomas
Meeting resources
1521O - A phase II biomarker-driven study evaluating the clinical efficacy of an MDM2 inhibitor, milademetan, in patients with intimal sarcoma, an ultra-rare cancer with highly life-threatening unmet medical needs (NCCH1806/MK004)
Presenter: Yuki Kojima
Session: Proffered Paper session - Sarcoma
Resources:
Abstract
1520O - REGISTRI: Regorafenib in first-line of KIT/PDGFR wild type advanced GIST: Capatalize the A Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial
Presenter: Javier Martin Broto
Session: Proffered Paper session - Sarcoma
Resources:
Abstract
LBA59 - LMS-04 study: A randomised, multicenter, phase III study comparing doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin in non-progressive patients as first-line therapy, in patients with metastatic or unresectable leiomyosarcoma - A French Sarcoma Group study
Presenter: Patricia Pautier
Session: Proffered Paper session - Sarcoma
Resources:
Abstract
LBA58 - Results of the randomized, placebo (PL)-controlled phase II study evaluating the efficacy and safety of regorafenib (REGO) in patients (pts) with relapsed advanced or metastatic chordoma, on behalf of the French Sarcoma Group (FSG) and Unicancer
Presenter: Florence Duffaud
Session: Proffered Paper session - Sarcoma
Resources:
Abstract
1527MO - Biomarkers of response and hyperprogression in patients with sarcoma treated with checkpoint blockade
Presenter: Nicholas Klemen
Session: Mini oral session - Sarcoma
Resources:
Abstract